EndoShape secures more than $14 million in funding

BOULDER — EndoShape, a medical device company that makes polymer vascular plugs and coils, recently closed on more than $14 million in funding, according to a Form D filed with the Securities and Exchange Commission.

EndoShape’s flagship product, the Medusa MultiCoil, is a device used for the embolization, or blocking, of blood vessels. It’s used to close off vessels that might be ruptured and causing internal bleeding or vessels that are feeding a tumor.

The Boulder company filed an amendment on March 21 to a form filed in February 2016 for equity offered. About $10.49 million was sold.

SPONSORED CONTENT

How Platte River Power Authority is accelerating its energy transition

Platte River Power Authority, the community-owned wholesale electricity provider for Northern Colorado, has a history of bold initiatives.

When the company originally filed on February 10 last year, it was offering $9.9 million in equity and had sold $7 million.

In February of this year, EndoShape filed another new notice with the date of first sale on Jan. 23, 2017. The company was offering $6 million in equity and had sold just less than $4 million.

When EndoShape amended last year’s filing on Tuesday, the company noted that it had sold all of its offering amount.

EndoShape did not immediately respond to requests for comment.